New drug RO7806881 put to the test in healthy volunteers
NCT ID NCT07271693
First seen Jan 06, 2026 · Last updated May 30, 2026 · Updated 28 times
Summary
This early-stage study tests whether a new drug called RO7806881 is safe and tolerable in healthy adults. About 128 participants will receive either the drug or a placebo, with doses increased gradually. The goal is to check for side effects and how the drug moves through the body, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
New Zealand Clinical Research - Christchurch
RECRUITINGChristchurch, 8011, New Zealand
Conditions
Explore the condition pages connected to this study.